» Authors » Charles Chiu

Charles Chiu

Explore the profile of Charles Chiu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 1134
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fallon B, Kuvaldina M, Zubcevik N, DeBiasi R, Mulkey S, Chiu C, et al.
Front Med (Lausanne) . 2025 Mar; 12:1519163. PMID: 40070652
Background: Research on patients with persistent symptoms despite prior treatment for Lyme disease can be challenging to interpret given the diversity of criteria selected to characterize Lyme disease and to...
2.
Griffin I, Smith D, Annambhotla P, Gold J, Ostrosky-Zeichner L, Kauffman C, et al.
Transpl Infect Dis . 2024 Jul; 26(5):e14331. PMID: 39012471
Background: Five organs (heart, right lung, liver, right, and left kidneys) from a deceased patient were transplanted into five recipients in four US states; the deceased patient was identified as...
3.
Thebault S, Gandelman S, Lane C, Kim E, Pileggi C, Zuroff L, et al.
Neurol Neuroimmunol Neuroinflamm . 2023 Aug; 10(5). PMID: 37562975
Objectives: The objective of this study was to report on the development of neuroinvasive West Nile virus (WNV) infection in the context of anti-CD20 monotherapy for multiple sclerosis (MS). Methods:...
4.
Garcia-Knight M, Anglin K, Tassetto M, Lu S, Zhang A, Goldberg S, et al.
PLoS Pathog . 2022 Sep; 18(9):e1010802. PMID: 36095030
The impact of vaccination on SARS-CoV-2 infectiousness is not well understood. We compared longitudinal viral shedding dynamics in unvaccinated and fully vaccinated adults. SARS-CoV-2-infected adults were enrolled within 5 days...
5.
Zhu C, Lee J, Woo J, Xu L, Nguyenla X, Yamashiro L, et al.
Nat Commun . 2022 Aug; 13(1):4503. PMID: 35922434
The COVID-19 pandemic is exacting an increasing toll worldwide, with new SARS-CoV-2 variants emerging that exhibit higher infectivity rates and that may partially evade vaccine and antibody immunity. Rapid deployment...
6.
Kelly J, Lu S, Anglin K, Garcia-Knight M, Pineda-Ramirez J, Goldberg S, et al.
Clin Infect Dis . 2022 Jul; 75(Suppl 2):S193-S204. PMID: 35788827
Background: Households have emerged as important venues for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Little is known, however, regarding the magnitude and determinants of household transmission in increasingly...
7.
DeVoe C, Pandey S, Shariff D, Arora S, Henrich T, Yokoe D, et al.
Transpl Infect Dis . 2022 Apr; 24(6):e13835. PMID: 35426225
The effect of vaccination on severity of subsequent COVID-19 in patients with hematologic malignancies (HMs) is unknown. In this single-center retrospective cohort study, we found no difference in severity of...
8.
Maruthamuthu S, Rajalingam K, Kaur N, Morvan M, Soto J, Lee N, et al.
Front Genet . 2022 Mar; 13:845474. PMID: 35273641
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection causes coronavirus disease-2019 (COVID-19) in some individuals, while the majority remain asymptomatic. Natural killer (NK) cells play an essential role in antiviral...
9.
Rodgers M, Olivo A, Harris B, Lark C, Luo X, Berg M, et al.
J Clin Virol . 2022 Jan; 147:105080. PMID: 35086043
Background: Viral diversity presents an ongoing challenge for diagnostic tests, which need to accurately detect all circulating variants. The Abbott Global Surveillance program monitors severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)...
10.
Miller S, Chiu C
Clin Chem . 2021 Dec; 68(1):115-124. PMID: 34969106
Background: Metagenomic next-generation sequencing (mNGS) for pathogen detection is becoming increasingly available as a method to identify pathogens in cases of suspected infection. mNGS analyzes the nucleic acid content of...